Publication | Open Access
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
132
Citations
23
References
2019
Year
These results reveal a P-gp-independent mechanism through ROS generation for the SKN/PTX combination to overcome MDR in ovarian cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1